The National Health Service (Pharmaceutical Services) Regulations 2012

Change of ownership applications

26.—(1) Section 129(2A) and (2B) of the 2006 Act (regulations as to pharmaceutical services) do not apply to an application from a person who is not included in a pharmaceutical list of a Primary Care Trust for inclusion in the list, or from a person included in a pharmaceutical list for inclusion in that list also in respect of other premises than those already listed in relation to that person, if—

(a)the applicant (X) is undertaking to provide pharmaceutical services at premises—

(i)that are already listed chemist premises, and

(ii)at which another person (Y) is providing pharmaceutical services;

(b)X is proposing to carry on at the listed chemist premises, in place of Y, the business in the course of which Y is providing pharmaceutical services at those premises;

(c)X is undertaking to provide the same pharmaceutical services as those that Y is providing; and

(d)the provision of pharmaceutical services at the premises will not be interrupted (except for such period as the Primary Care Trust may for good cause allow).

(2) Section 129(2A) and (2B) of the 2006 Act do not apply to an application from a person who is not included in a pharmaceutical list of a Primary Care Trust (PCTX) for inclusion in that list, or from a person included in a pharmaceutical list for inclusion in that list also in respect of other premises than those already listed in relation to that person, if—

(a)the applicant (X) is undertaking to provide the pharmaceutical services that another person (Y)—

(i)is providing at listed chemist premises (“Y’s premises”), whether in the area of PCTX or another Primary Care Trust, or

(ii)has provided at Y’s premises but Y is no longer able to provide pharmaceutical services at those premises for reasons that PCTX accepts are good cause;

(b)X is proposing to carry on, in place of Y, the business in the course of which Y is providing, or has provided, pharmaceutical services at Y’s premises;

(c)X is undertaking to provide the same pharmaceutical services as Y is providing or has provided at Y’s premises, but at different premises (“X’s premises”);

(d)if Y had applied to move to X’s premises, that application would have been granted under regulation 24; and

(e)if pharmaceutical services—

(i)are being provided at Y’s premises, the provision of pharmaceutical services will not be interrupted (except for such period as PCTX may for good cause allow) by the move of the business from Y’s premises to X’s premises, or

(ii)are not being provided at Y’s premises, the provision of pharmaceutical services will commence at X’s premises within the period that PCTX considers is an acceptable period for the interruption of the provision of pharmaceutical services by the business that X is taking over.